[Treatment with erythropoietin and iron requirements in dialyzed patients].
The use of erythropoietin in dialysed patients leads to the gradual depletion of the body's iron reserves. It is important to assay iron blood levels in both patients receiving Epo therapy and those undergoing dialysis without this treatment. The most common method used is to assay ferritinemia, transferrinemia and the transferrin saturation levels. Using a retrospective study it was found that there is no significant difference in the request for iron supplementation in patients receiving Epo treatment compared to a control group not treated with Epo.
Montalcini
G
G
USSL 68, Regione Piemonte Ospedale Civile, Asti.
Imarisio
P
P
Bongiorno
P
P
Biamino
E
E
Caligaris
F
F
Demicheli
G
G
D000328:Adult; D000368:Aged; D004921:Erythropoietin / Q000009:adverse effects*; D006801:Humans; D007501:Iron / Q000627:therapeutic use*; D000090463:Iron Deficiencies; D008875:Middle Aged; D006435:Renal Dialysis; D012189:Retrospective Studies
D004921:Erythropoietin; D007501:Iron